Literature DB >> 30895882

Post-pandemic influenza-associated mortality in Mexico.

Jack N Salto-Quintana1,2, Gerardo Rivera-Alfaro1, Evelyn L Sánchez-Ramos3, Alejandro Gómez-Gómez2, Daniel E Noyola1.   

Abstract

Influenza is a leading cause of respiratory tract infections worldwide and there is limited information on the impact of the influenza A(H1N1)pdm virus on mortality after the 2009 pandemic. Using national mortality register data through 1998-2015 in Mexico, influenza-associated mortality was estimated for respiratory, cardiovascular, and all-cause events. The proportion of influenza-associated respiratory and cardiovascular deaths among different age groups were compared. There were 8,853,986 death registries included for the 1998-2015 winter seasons, average influenza-associated respiratory, cardiovascular, and all-cause mortality rates were 5.2, 6.3, and 19.6 deaths/100,000 population, respectively. The largest number of respiratory influenza-associated deaths occurred in adults 60 years of age and older, followed by children <5 years of age; during the 2009 pandemic, 2011-2012, and 2013-2014 winter seasons there was a larger number of deaths in the 20-59 years old group. Influenza-associated mortality rates showed a continuous reduction in children <5 years of age. After the 2009 pandemic, influenza A(H1N1)pdm09 virus-associated mortality in Mexico showed a persistent change in the demographic pattern of the most severely affected population, particularly during the 2013-2014 season. Influenza associated-mortality has decreased in children <5 years of age and continue to be elevated in adults >60 years of age.

Entities:  

Keywords:  Influenza; influenza A(H1N1)pdm09; mortality; pandemic; pneumonia; respiratory infections

Mesh:

Year:  2019        PMID: 30895882      PMCID: PMC6493299          DOI: 10.1080/20477724.2019.1589211

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  24 in total

Review 1.  Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

Authors:  Edgar Bautista; Tawee Chotpitayasunondh; Zhancheng Gao; Scott A Harper; Michael Shaw; Timothy M Uyeki; Sherif R Zaki; Frederick G Hayden; David S Hui; Joel D Kettner; Anand Kumar; Matthew Lim; Nahoko Shindo; Charles Penn; Karl G Nicholson
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

2.  The signature features of influenza pandemics--implications for policy.

Authors:  Mark A Miller; Cecile Viboud; Marta Balinska; Lone Simonsen
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

3.  Methods for current statistical analysis of excess pneumonia-influenza deaths.

Authors:  Robert E Serfling
Journal:  Public Health Rep       Date:  1963-06       Impact factor: 2.792

4.  Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico.

Authors:  Rogelio Perez-Padilla; Daniela de la Rosa-Zamboni; Samuel Ponce de Leon; Mauricio Hernandez; Francisco Quiñones-Falconi; Edgar Bautista; Alejandra Ramirez-Venegas; Jorge Rojas-Serrano; Christopher E Ormsby; Ariel Corrales; Anjarath Higuera; Edgar Mondragon; Jose Angel Cordova-Villalobos
Journal:  N Engl J Med       Date:  2009-06-29       Impact factor: 91.245

5.  Severe atypical pneumonia outbreak associated with influenza A(H1N1)pdm09 in Egypt, 2013–2014 season.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-04-18

6.  Influenza A pandemics of the 20th century with special reference to 1918: virology, pathology and epidemiology.

Authors:  J S Oxford
Journal:  Rev Med Virol       Date:  2000 Mar-Apr       Impact factor: 6.989

7.  Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza.

Authors:  Vivek Charu; Gerardo Chowell; Lina Sofia Palacio Mejia; Santiago Echevarría-Zuno; Víctor H Borja-Aburto; Lone Simonsen; Mark A Miller; Cécile Viboud
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

8.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans.

Authors:  Fatimah S Dawood; Seema Jain; Lyn Finelli; Michael W Shaw; Stephen Lindstrom; Rebecca J Garten; Larisa V Gubareva; Xiyan Xu; Carolyn B Bridges; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

9.  Mortality attributable to pandemic influenza A (H1N1) 2009 in San Luis Potosí, Mexico.

Authors:  Andreu Comas-García; Christian A García-Sepúlveda; José J Méndez-de Lira; Saray Aranda-Romo; Alba E Hernández-Salinas; Daniel E Noyola
Journal:  Influenza Other Respir Viruses       Date:  2010-11-03       Impact factor: 4.380

10.  Mortality associated with influenza in tropics, state of são paulo, Brazil, from 2002 to 2011: the pre-pandemic, pandemic, and post-pandemic periods.

Authors:  André Ricardo Ribas Freitas; Priscila M S Bergamo Francisco; Maria Rita Donalisio
Journal:  Influenza Res Treat       Date:  2013-06-12
View more
  2 in total

1.  Potency of Lianhua Qingwen granule combined with paramivir sodium chloride injection in treating influenza and level changes of serum inflammatory factors.

Authors:  Jinhua Wu; Qian Wang; Liu Yang; Zhicun Li; Xin Wang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).

Authors:  José Alberto Choreño-Parra; Luis Armando Jiménez-Álvarez; Alfredo Cruz-Lagunas; Tatiana Sofía Rodríguez-Reyna; Gustavo Ramírez-Martínez; Montserrat Sandoval-Vega; Diana Lizzeth Hernández-García; Eduardo M Choreño-Parra; Yalbi I Balderas-Martínez; Mariana Esther Martinez-Sánchez; Eduardo Márquez-García; Edda Sciutto; José Moreno-Rodríguez; José Omar Barreto-Rodríguez; Hazel Vázquez-Rojas; Gustavo Iván Centeno-Sáenz; Néstor Alvarado-Peña; Citlaltepetl Salinas-Lara; Carlos Sánchez-Garibay; David Galeana-Cadena; Gabriela Hernández; Criselda Mendoza-Milla; Andrea Domínguez; Julio Granados; Lula Mena-Hernández; Luis Ángel Pérez-Buenfil; Guillermo Domínguez-Cheritt; Carlos Cabello-Gutiérrez; Cesar Luna-Rivero; Jorge Salas-Hernández; Patricio Santillán-Doherty; Justino Regalado; Angélica Hernández-Martínez; Lorena Orozco; Federico Ávila-Moreno; Ethel A García-Latorre; Carmen M Hernández-Cárdenas; Shabaana A Khader; Albert Zlotnik; Joaquín Zúñiga
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.